Author: admin

Continue Reading

  • Computationally guided defect-suppressing synthesis of luminescent tin halide perovskite nanocrystals

    Computationally guided defect-suppressing synthesis of luminescent tin halide perovskite nanocrystals

  • Dey, A. et al. State of the art and prospects for halide perovskite nanocrystals. ACS Nano 15, 10775–10981 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Shamsi, J., Urban,…

  • Continue Reading

  • Hesperidin exacerbates the therapeutic potency of cisplatin against hepatocytotoxicity of Ehrlich ascites carcinoma in mice

    Hesperidin exacerbates the therapeutic potency of cisplatin against hepatocytotoxicity of Ehrlich ascites carcinoma in mice

  • Singh, S., Sharma, B., Kanwar, S. S. & Kumar, A. Lead phytochemicals for anticancer drug development. Front. Plant Sci. 7, 1667 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hanahan,…

  • Continue Reading

  • Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis

    Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis

  • Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat. Rev. Immunol. 13, 88–100 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Continue Reading

  • Production and characterization of anti-bacterial metabolite(s) from Egyptian archaeological sites

    Production and characterization of anti-bacterial metabolite(s) from Egyptian archaeological sites

    Microorganisms

    Different bacterial and fungal multidrug-resistant (MDR) pathogens were used throughout the present work, namely: Methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus aureus, Escherichia coli, Candida albicans,…

    Continue Reading

  • The hidden human cost of defunded LGBTQIA+ health research

    Thank you to all LGBTQIA+ health researchers and those affected by grant terminations for their continued leadership in their respective fields. A special thank you to the LGBTQIA+ communities who continue to embrace us even as we are losing…

    Continue Reading

  • p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy

    p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy

  • Goutsouliak, K. et al. Towards personalized treatment for early stage HER2-positive breast cancer. Nat. Rev. Clin. Oncol. 17, 233–250 (2020).

    Article 
    PubMed 

    Google Scholar 

  • Rimawi, M. F., Schiff,…

  • Continue Reading

  • ADAT3-related neurodevelopmental disorder in 24 new patients with a high frequency of the p.Val144Met and a new founder variant

    ADAT3-related neurodevelopmental disorder in 24 new patients with a high frequency of the p.Val144Met and a new founder variant

    ADAT3-related neurodevelopmental disorder is very rare with only 60 patients from 29 unrelated families reported in the literature4,5,7,8,10,11,12,13,27. Our study reports an additional 24 patients and significantly substantiates the clinical and…

    Continue Reading

  • An experimental proxy of water displaceability for ligand discovery

    An experimental proxy of water displaceability for ligand discovery

  • Lee, Y.-H. et al. Crystal structure of a trapped phosphoenzyme during a catalytic reaction. Nat. Struct. Biol. 4, 615–618 (1997).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Keedy, D. A. et al….

  • Continue Reading